首页 >
法规速递
-
关于药品注册申请电子申报有关要求的通知-2022/12/2
2022-12-02查看详情 > -
关于公开征求《抗体偶联药物药学研究与评价技术指导原则（征求意见稿）》意见的通知-2023/6/21
2023-06-21查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第七十四批）的通告（2023年第67号）-2023/12/26
2024-01-03查看详情 > -
国家药监局关于32批次不符合规定化妆品的通告（2025年第6号） -2025/1/21
2025-01-23查看详情 > -
Document: Medicinal products for human use: monthly figures - January 2025-2025/2/25
2025-02-27查看详情 > -
Page: Tolvaptan product-specific bioequivalence guidance-2025/4/2
2025-04-03查看详情 > -
Document: Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026-2025/5/13
2025-05-14查看详情 > -
Document: Concept paper for the development of a guideline on the methodology of environmental risk assessment for ectoparasiticidal VMPs for cats and dogs-2025/6/20
2025-06-23查看详情 > -
Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders-2025/7/25
2025-07-27查看详情 > -
Development of Non-Opioid Analgesics for Chronic Pain-2025/9/10
2025-09-11查看详情 >
